Plain-English translation of NCT07427043 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 3 โ Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new approach to managing pain after robotic prostate removal surgery โ one that relies on non-opioid pain relief methods instead of traditional opioid painkillers after you leave the hospital. The study will compare three groups: patients receiving standard care (with opioids), patients offered opioid-free pain management with the option to request opioids by phone if needed, and patients given opioid-free pain management plus a small opioid prescription just in case. The goal is to see whether patients can heal well and stay comfortable without relying heavily on opioid medications.
Opioid painkillers, while effective, carry real risks of addiction and other serious side effects โ especially when prescribed after surgery. This trial exists to find out whether a combination of other pain relief methods can work just as well, helping reduce unnecessary opioid use while keeping patients safe and comfortable.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will meet with the research team before your scheduled prostate surgery to learn about the pain management plan. After your surgery, you will receive multimodal pain relief โ a combination of non-opioid medications and techniques โ rather than routine opioid prescriptions. Depending on which group you are assigned to, you may receive written pain management instructions only, or those instructions plus a small opioid prescription to fill just in case. You will be tracked to see how well your pain is controlled and how many opioids you actually use after going home.
AI-generated summary from trial data ยท Jun 3, 2026 ยท Not medical advice
United States